MagForce Nanotechnologies AG is the global leader in the field of nanotechnology cancer treatment. This revolutionary technology aims to establish a entirely new form of cancer treatment within the near future, using magnetic particles to treat tumors with very minimal side effects, thus enhancing patient quality of life. The technology and its related equipment are currently in the final phases of clinical trials. Until these have been successfully concluded, the products can only be used in conjunction with clinical trials. The products can only be sold and used in normal clinical practice once they have received regulatory approval from the responsible authorities.